Noggo E.v.

What Noggo E.v. does

NOGGO E.V. (Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie) is a Berlin-based registered nonprofit medical professional society founded in 1998 to improve recurrence-free survival and life expectancy of patients with gynecologic cancers. It is the largest membership organization in the field in Germany, with approximately 900–950 physician and medical professional members drawn from hospitals and private practices, and operates through 8 specialized working groups covering ovarian, breast, cervical and endometrial cancers, translational research, supportive therapies, global health, and benefit assessment of innovations, plus the JAGO (Young Academy Gynecologic Oncology) fellowship program founded in 2013.

The society's core offerings are clinical trial design and management (15+ active ENGOT-branded Phase I–IV trials), the EXPRESSION international patient survey series, accredited continuing medical education events including the annual "360° GYN-ONKOLOGIE" conference, webinars, masterclasses, and a members-only Mediathek of archived presentations, and the proprietary NOGGO GIS V1 HRD Assay validated in collaboration with the Institute for Hematopathology Hamburg and the ENGOT-PAOLA1 study group. NOGGO operates the Tumorbank Ovarian Cancer Network (TOC) at Charité Universitätsmedizin Berlin and integrates standard research tooling (RedCap, SurveyMonkey, doctorflix video platform). It coordinates with ENGOT, GCIG, AGO, DGHO, DGGG, and DAGG (patronage of JAGO).

Revenue is generated through tiered annual membership fees (€45–€75 per member, free for students) and "Fördermitgliedschaft" sponsor memberships from selected pharmaceutical companies including GSK, MSD, AstraZeneca, Roche, Daiichi Sankyo, Seagen, pharmaand, Clovis Oncology, PharmaMar, and Tesaro (historical). Sponsorship funds are concentrated in the JAGO fellowship program, where sponsors are explicitly barred from influencing educational content or fellow selection. The organization is governed by a board chaired by Prof. Dr. Dr. h.c. Jalid Sehouli and managed operationally by Managing Director Dr. Anna Oldenburg, supported by a lean ~12-person Berlin staff.

Name

Noggo E.v.

Legal name

Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie e. V.

Website

https://noggo.de

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

NOGGO E.V. is a Berlin-based nonprofit medical professional society serving approximately 950 gynecologic oncology physicians in Germany, operating clinical trials, the EXPRESSION patient survey series, continuing medical education, and the JAGO fellowship program, funded by membership fees and pharmaceutical industry sponsorships.

Ownership category

akta.pro rank

Product category

Medical Professional Society

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAKAFAF

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

SECONDARYHLAKAJAD

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLAFAJAK

Gynecologic Oncology & Women’s Cancer Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

Keywords

• Gynecologic oncology research
• Clinical trial services
• Continuing medical education
• Medical professional society
• Patient outcomes research

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Membership Fees: Annual membership fees are the primary revenue stream. Fees vary by professional category: attending physicians (Chefärztin/Chefarzt) pay €75/year; senior physicians (Oberärztin/Oberarzt) pay €60/year; resident/office-based physicians pay €45/year; students attend free of charge. Pharmaceutical companies support the society through 'Fördermitgliedschaft' (sponsor membership).
2. Industry Sponsorship & Grants: Pharmaceutical companies (e.g., GSK, MSD, AstraZeneca, Roche, Daiichi Sankyo, Seagen, pharmaand, Clovis Oncology, PharmaMar, Tesaro) provide financial sponsorship for educational programs, particularly the JAGO (Young Academy Gynecologic Oncology) fellowship program. Sponsors do not influence educational content or selection processes.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

NOGGO E.V. is a nonprofit medical professional society that conducts multi-center clinical studies, runs longitudinal patient surveys (e.g., EXPRESSION series), and delivers continuing medical education, fellowships, and translational research programs in gynecologic oncology. It coordinates working groups across ovarian, breast, cervical/endometrial, supportive therapy, and health technology assessment topics, and operates the Tumorbank Ovarian Cancer Network biobank.

Product overview

NOGGO e.V. (Nord-Ostdeutsche Gesellschaft für Gynäkologische Onkologie) is a professional medical society and research organization operating as a unified digital platform and program portfolio. The core offering combines a member-accessible website platform with integrated clinical research services, the EXPRESSION patient survey series, educational programming (including Masterclass, JAGO fellowship, webinars, and annual conferences), media library access, and scientific publication support. The organization functions as a network of approximately 950 members facilitating clinical trials and professional education in gynecological oncology across Germany.

Differentiator

Problem solved

Functional benefit

Brands

• JAGO: Junge Akademie gynäkologische Onkologie: A career development and training program for young physicians in gynecological oncology, offering a curriculum of five modules, workshops, project groups, and networking opportunities with senior leaders.

Products and services

• JAGO Fellowship Program Structured post-doctoral fellowship program for young physicians and trainees specializing in gynecologic oncology; combines clinical rotation, research training, and mentorship.
• Educational Events (Fortbildungsveranstaltungen) Continuing medical education events including conferences, symposia, workshops, and webinars focused on gynecologic oncology practice and research.
• Clinical Studies (Klinische Studien) Multi-center investigator-initiated clinical trials and translational research studies in gynecologic oncology, conducted in collaboration with academic sites and industry sponsors.
• EXPRESSION Patient Survey Series Longitudinal patient-reported outcomes survey program tracking quality of life, treatment experiences, and psychosocial outcomes of gynecologic cancer patients.
• Annual Society Membership Annual membership in NOGGO E.V. providing access to the Mediathek educational content library, working group participation, and member events; tiered pricing with reduced rates for students and trainees.

Quantifiable outcome

• NOGGO members receive a 30% discount on ESGO membership fees
• +4 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• ENGOT (European Network of Gynaecological Oncological Trial Groups)coreStrategic or Co-development PartnerNOGGO is an active member of ENGOT and conducts multiple ENGOT-branded clinical trials (ENGOT-ov93/TREVI, ENGOT-ov89, ENGOT-en34, ENGOT-en24, ENGOT-en25, ENGOT-en29, ENGOT-ov83, ENGOT-ov51, ENGOT-ov65, ENGOT-Cx19, ENGOT-en10/DUO-E, ENGOT-en12, ENGOT-en15, ENGOT-en31, ENGOT-ov47-TR). NOGGO also coordinates European patient surveys within the ENGOT framework.
• GCIG (Gynecological Cancer InterGroup)coreStrategic or Co-development PartnerNOGGO collaborates with GCIG on international patient surveys (Expression VI, Expression IX) and clinical trial consensus statements, contributing to global harmonization of gynecologic cancer research.
• AGO (Arbeitsgemeinschaft Gynäkologische Onkologie) / AGO StudiengruppecoreStrategic or Co-development PartnerNOGGO collaborates with AGO-Studiengruppe on clinical trials (e.g., AG Ovarialkarzinom working with the OVAR commission, AGO-Studiengruppe, and the European Competence Center for Ovarian Cancer / EKZE at Charité). NOGGO and AGO have cooperated for over 20 years.
• DGHO (Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie)minorStrategic or Co-development PartnerNOGGO works with DGHO in drafting statements for the Gemeinsamer Bundesausschuss (G-BA) within the benefit assessment procedure for gynecologic oncology innovations.
• DGGG (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe)minorStrategic or Co-development PartnerNOGGO collaborates with DGGG in drafting statements for the G-BA benefit assessment procedure.
• Charité Universitätsmedizin BerlincoreStrategic or Co-development PartnerCharité is the primary academic partner of NOGGO. Several NOGGO leaders (Prof. Dr. Klaus Pietzner, Prof. Dr. Dr. h.c. Jalid Sehouli) hold positions at Charité. NOGGO operates the European biobank (TOC/Tumorbank Ovarian Cancer Network) at Charité and conducts multiple collaborative clinical trials.
• DAGG (Deutsche Akademie für Gynäkologische Onkologie) - PatronageminorStrategic or Co-development PartnerDAGG provides the patronage (Schirmherrschaft) for the JAGO (Young Academy Gynecologic Oncology) program.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Society of Gynecologic Oncology (SGO): SGO is the leading US-based gynecologic oncology professional society. It is comparable as a specialty medical society with similar mission (research, education, advocacy) but operates primarily in North America rather than DACH.

Emerging players

• Stiftung Eierstockkrebs: A German patient advocacy foundation focused on ovarian cancer that NOGGO collaborates with for patient outreach. It is comparable as a stakeholder organization in the German gynecologic oncology ecosystem.

Broad incumbents

• European Society for Medical Oncology (ESMO): ESMO is a broader European oncology professional society whose audience overlaps with NOGGO members. It is comparable as a larger incumbent serving medical oncology professionals across all cancer types.
• International Gynecologic Cancer Society (IGCS): IGCS is the leading international society for gynecologic cancer research and education. It is comparable as a higher-level international professional body serving the same specialty community.
• European Society of Gynaecological Oncology (ESGO): ESGO is the broader European society for gynecologic oncology. NOGGO members receive a 30% discount on ESGO membership, indicating direct overlap in audience and educational programming across Europe.

Others

• Gynecological Cancer InterGroup (GCIG): GCIG is an international consortium of trial groups coordinating gynecologic cancer research. NOGGO is an active GCIG collaborator, making GCIG directly comparable as a coordinating network for the same clinical research agenda.
• European Network of Gynaecological Oncological Trial Groups (ENGOT): ENGOT is the European cooperative network for gynecologic cancer trial groups. NOGGO is a member and runs multiple ENGOT-branded trials, making ENGOT a directly comparable trial coordination platform.

Direct peers

• Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG): DGGG is the umbrella German OB/GYN professional society. NOGGO collaborates with DGGG on G-BA statements; it is comparable as a peer physician society addressing overlapping gynecologic topics.
• Arbeitsgemeinschaft Gynäkologische Onkologie (AGO): AGO is the other major German gynecologic oncology professional society with whom NOGGO cooperates on trials (AGO-Studiengruppe, EKZE). It is directly comparable as a parallel physician society focused on gynecologic cancers in the same geography.
• Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO): DGHO is the German professional society for hematology and medical oncology, with whom NOGGO collaborates on G-BA benefit assessment statements. It is directly comparable as a German physician society focused on oncology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/noggo

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Noggo E.v.